Research News
Ovarian Cancer Canada funds research into prevention, improved treatments, and ultimately a cure. Science continues to uncover new knowledge that impacts treatment and survival. Here’s how.
This is the second in a series of articles about advances in the field of ovarian cancer research. Our thanks to Dr. Barbara Vanderhyden (see bio at end) for preparing this series of lay articles for our readers.
Research holds the key to ovarian cancer prevention, early detection, treatment and ultimately, a cure.
Dr. Anne-Marie Mes-Masson to receive national research award
The Canadian Institutes of Health Research (CIHR) has selected a project led by Dr. Michelle Scott, Université de Sherbrooke, for Ovarian Cancer Bridge Funding.
New research shows that women who regularly use pain relief medications, particularly aspirin, have a decreased risk of serous ovarian cancer—an aggressive carcinoma affecting the surface of the ovary.
A champion for women living with ovarian cancer, Pat McDonald has done everything from co-chairing the Ovarian Cancer Canada Walk of Hope to serving on our Board of Directors to leading Knowledge is Power and Survivors Teaching Students® awareness sessions. A veritable force of nature, she has attended nearly every event in and around Halifax, gathering a faithful following over the years.
Women living with ovarian cancer and their families recently had the opportunity to hear directly from scientists as part of a session called “Ovarian Cancer Research and You.” This special presentation was held in conjunction with the 8th Canadian Conference on Ovarian Cancer Research, which convened leading minds in the field.
Ovarian Cancer Canada alongside GOC wishes to congratulate the members of the research team for translating ongoing research on the connection between fallopian tubes and ovarian cancer into clinical practice.
Ovarian Cancer Canada is a proud program collaborator in the exciting Terry Fox Research Institute (TFRI) initiative that seeks to change how ovarian cancer is diagnosed and managed worldwide.
People who financially support the cause of overcoming ovarian cancer – “the most lethal women’s cancer” – have a “moderate to high donor opportunity for impact,” according to a recent research report by Charity Intelligence Canada (Ci).